A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2004
12/29/2004	WO2004112747A2 Specific delivery of drugs to the brain
12/29/2004	WO2004112746A1 Controlled release-drug delivery system for oral administration
12/29/2004	WO2004112724A2 Compositions for and methods for treating hiv
12/29/2004	WO2004112717A2 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
12/29/2004	WO2004112713A2 Drug polymer complexes
12/29/2004	WO2004112711A2 Oral extended-release composition
12/29/2004	WO2004112696A2 Methods and compositions for delivery of catecholic butanes for treatment of diseases
12/29/2004	WO2004112695A2 Methods and compositions for delivery of catecholic butanes for treatment of obesity
12/29/2004	WO2004112630A2 A formulation and a process for reducing the deterioration of blood with particular reference to decrease in the level of 2,3 diphosphoglycerate during storage
12/29/2004	WO2004112476A1 Biomaterial preservation methods
12/29/2004	WO2004096152A3 In situ gelling self-reactive materials for embolization
12/29/2004	WO2004091512A3 Abuse-resistant oral dosage forms and method of use thereof
12/29/2004	WO2004089334A3 Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
12/29/2004	WO2004088029A3 Disposable, paper-based hospital and operating theater products
12/29/2004	WO2004084819A3 Poly(acryloyl-hydroxyethyl starch)-plga composite microspheres
12/29/2004	WO2004080415A3 Gel composition and method for treatment of vaginal infections
12/29/2004	WO2004075875A8 Dosage form having a saccharide matrix
12/29/2004	WO2004073551A3 Transscleral drug delivery device and related methods
12/29/2004	WO2004071469A3 Methods of administering a dermatological agent to a subject
12/29/2004	WO2004071268A3 Gas accumulator for storing a predetermined gas quantity and for releasing said gas for medical use
12/29/2004	WO2004066984A3 Improved taste masking pharmaceutical composition and process for its preparation
12/29/2004	WO2004058329A3 Ester combination local anesthetic
12/29/2004	WO2004050062A3 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
12/29/2004	WO2004043433A3 Pharmaceutical antiviral compositions
12/29/2004	WO2004037225A3 Cosmetic and pharmaceutical foam
12/29/2004	WO2004004684A8 Controlled-release pharmaceutical formulations
12/29/2004	WO2003082370A3 Transcellular drug delivery system
12/29/2004	WO2003035790A9 Improved method for generating an aerosol
12/29/2004	WO2003015701A3 Lipobeads and their production
12/29/2004	EP1491236A1 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
12/29/2004	EP1491233A1 Medical treatment system and production method therefor
12/29/2004	EP1491217A1 Stabilization of polynucleotide complexes
12/29/2004	EP1491216A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
12/29/2004	EP1491215A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
12/29/2004	EP1491214A1 Drugs for treating liver diseases with the use of hollow protein nanoparticles
12/29/2004	EP1491210A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
12/29/2004	EP1491208A1 Stabilized liquid polypeptide-containing pharmaceutical compositions
12/29/2004	EP1491203A1 Compositions for treating and/or preventing pollenosis
12/29/2004	EP1491202A1 Nail restructuring compositions for topical application
12/29/2004	EP1491199A1 Pharmaceutical compositions of alendronate sodium trihydrate and process for the preparation thereof
12/29/2004	EP1491193A1 Therapeutic combinations comprising amlodipine and atorvastatin
12/29/2004	EP1491189A1 Diclofenac sodium oral pharmaceutical
12/29/2004	EP1491184A1 Soft tablet containing high molecular weight cellulosics
12/29/2004	EP1490146A1 Device for intradermal medicament delivery
12/29/2004	EP1490143A1 Valved intradermal delivery device
12/29/2004	EP1490121A1 Drug delivery particle
12/29/2004	EP1490120A1 Embolization
12/29/2004	EP1490119A1 Tissue treatment
12/29/2004	EP1490096A1 Use of hydrogen peroxide producing enzyme for treatment of otitis media
12/29/2004	EP1490095A1 Stable pharmaceutical composition containing factor viii
12/29/2004	EP1490083A1 Microgel particles for the delivery of bioactive materials
12/29/2004	EP1490079A1 A composition for treating gastric ulcer and a process for preparing the same
12/29/2004	EP1490078A1 Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytochrome p-450
12/29/2004	EP1490075A2 Bioadhesive directed somatic cell therapy
12/29/2004	EP1490068A1 Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
12/29/2004	EP1490059A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
12/29/2004	EP1490052A1 Device for the transdermal administration of a rotigotine base
12/29/2004	EP1490041A1 Treatment of female sexual dysfunction
12/29/2004	EP1490039A2 Assembled unit consisting of individually separable transdermal therapeutic systems
12/29/2004	EP1490038A1 Hybrid system for solubilizing pharmaceutically active substances in polymer matrices
12/29/2004	EP1490037A1 Taste masked veterinary solid compositions
12/29/2004	EP1490036A1 Sustained release formulation of tramadol
12/29/2004	EP1490035A1 Intraorally disintegrating valdecoxib compositions
12/29/2004	EP1490034A1 Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions
12/29/2004	EP1490033A1 No-donating nsaids adsorbed into carrier particles
12/29/2004	EP1490032A1 Processes for manufacturing polymeric microspheres
12/29/2004	EP1490031A1 Fast melt multiparticulate formulations for oral delivery
12/29/2004	EP1490030A1 Nanoparticulate compositions of angiogenesis inhibitors
12/29/2004	EP1490029A1 Controlled release drug delivery system of pravastatin
12/29/2004	EP1490028A1 Delivery of a substance to a pre-determined site
12/29/2004	EP1490027A1 Methods for entrapment of bioactive agent in a liposome or lipid complex
12/29/2004	EP1490026A2 Atomizable liposomes and their use for the pulmonary administration of active substances
12/29/2004	EP1490025A2 Nanoparticulate compositions of map kinase inhibitors
12/29/2004	EP1490024A1 Effervescent compositions comprising bisphosphonates and methods related thereto
12/29/2004	EP1490011A1 System for orally administering active substances, vitamins and/or foodstuffs
12/29/2004	EP1490010A1 Administration form for oral administration of active ingredients, vitamins and/or nutrients
12/29/2004	EP1489988A1 Dispensing apparatus and cartridge
12/29/2004	EP1489983A2 Method and apparatus treating tissue adjacent a bodily conduit with thermocompression and drugs
12/29/2004	EP1489971A2 Methods for ultrasonic imaging and treating diseased tissues
12/29/2004	EP1439818B1 Chewable tablet containing lysine
12/29/2004	EP1399135B1 Methods for hermetically sealing microchip reservoir devices
12/29/2004	EP1379220B1 Inhalation capsules
12/29/2004	EP1361918B1 Method for making granules
12/29/2004	EP1328528B1 Pharmaceutical compositions comprising clavulanic acid
12/29/2004	EP1289931B1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
12/29/2004	EP1259114B1 A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
12/29/2004	EP1244657B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/29/2004	EP1244444B1 Process for formulation of carbapenem antibiotic compositions
12/29/2004	EP1225902B1 Ciclesonide contained pharmaceutical composition for application to mucosa
12/29/2004	EP1216048B1 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols
12/29/2004	EP1210069B1 Large porous particles obtainable by spray-drying and suitable for pulmonary administration
12/29/2004	EP1189688B1 W/o type emulsions with a high water content containing medium polar lipids
12/29/2004	EP1173127A4 Bandage having a scar treatment pad for scar management and scar repair
12/29/2004	EP1171103B1 Inactivated microorganisms comprising substances having pharmacological activity
12/29/2004	EP1163209A4 Compounds and compositions for delivering active agents
12/29/2004	EP1146959A4 Method and apparatus for liposome production
12/29/2004	EP1123084B1 Use of testosterone esters and/or testosterone for producing bucally applicable bio-adhesive systems with time-released active ingredients
12/29/2004	EP1117643B1 New crystal modification n of torasemide
12/29/2004	EP1096937B1 Sustained release ranolazine formulations
12/29/2004	EP1033953A4 Method of cross-linking keratin-based films, sheets, and bulk materials

1 ... 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 ... 2991